NIH
Jan 23, 2023
The ADAPT Study recruited men who have sex with men (MSM) and transgender women and was designed to identify oral pre-exposure prophylaxis (PrEP) pill-taking schedules that participants are more likely to follow and determine if these schedules influence healthier...
Jan 22, 2023
HPTN 076 was a two-year study that recruited sexually active women age 18 to 45 and evaluated the safety and acceptability of a new injectable HIV prevention medication, Rilpivirine, for use in healthy, HIV-uninfected women. Report Links: Seneviratne HK et al. 2020....
Jan 3, 2023
ICAP is conducting formative research to inform the design and implementation of combination prevention interventions, including pre-exposure prophylaxis (PrEP) for female sex workers, as well as to inform recruitment and retention strategies for female sex workers...
Dec 19, 2022
This study examined the drug levels of the antiretroviral agent tenofovir in rectal tissue after it has been used as a gel in the vagina and vice versa. Report Links: Justman J. et al, 2018. https://pubmed.ncbi.nlm.nih.gov/29767639/ Pharmacokinetics and...
Dec 18, 2022
ICAP collaborated with the CUNY School of Public Health, the HIV Center for Clinical and Behavioral Studies at Columbia University, and the Oromia Regional Health Bureau on a study to determine the multi-level factors associated with late antiretroviral therapy (ART)...
